4//SEC Filing
Margrave David R. 4
Accession 0001493152-25-028759
CIK 0001763950other
Filed
Dec 21, 7:00 PM ET
Accepted
Dec 22, 4:05 PM ET
Size
5.5 KB
Accession
0001493152-25-028759
Insider Transaction Report
Form 4
Margrave David R.
Chief Financial Officer
Transactions
- Award
Stock Option (Right to Buy)
2025-12-18+20,000→ 20,000 totalExercise: $3.24Exp: 2035-12-17→ Common Stock (20,000 underlying)
Footnotes (1)
- [F1]The Options are granted under the Lantern Pharma Inc. Amended and Restated 2018 Stock Incentive Plan. The Options shall vest and first become exercisable in equal monthly increments over a 24-month period commencing January 18, 2026.
Documents
Issuer
Lantern Pharma Inc.
CIK 0001763950
Entity typeother
Related Parties
1- filerCIK 0001813162
Filing Metadata
- Form type
- 4
- Filed
- Dec 21, 7:00 PM ET
- Accepted
- Dec 22, 4:05 PM ET
- Size
- 5.5 KB